The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Mitchell Krucoff
Showing 1-9 of 9 articles
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg G,
Angiolillo D,
Mehta SR,
Shlofmitz RA,
Sharma S,
Pocock S,
Gibson C,
Mehran R
December 2, 2022 | 10.4244/EIJ-D-22-00319
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike
Krucoff M,
Cao D,
Mehran R
August 19, 2022 | 10.4244/EIJ-E-22-00024
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen JF,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson TW,
Pan M,
Chatzizisis YS,
Banning AP,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone GW,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys PW,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients
Marquis-Gravel G,
Urban P,
Copt S,
Capodanno D,
Pocock S,
Sadozai Slama S,
Stoll H,
Tanguay J,
Mehran R,
Leon MB,
Rao SV,
Morice M,
Krucoff M
June 25, 2021 | 10.4244/EIJ-D-20-00749
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne RA,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone GW,
Lansky AJ,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys PW
January 17, 2020 | 10.4244/EIJ-D-19-00552
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Kappetein A,
Head S,
Généreux P,
Piazza N,
Van Mieghem NM,
Blackstone E,
Brott T,
Cohen D,
Cutlip D,
Van Es G-A,
Hahn R,
Kirtane AJ,
Krucoff M,
Kodali SK,
Mack M,
Mehran R,
Rodés-Cabau J,
Vranckx P,
Webb JG,
Windecker S,
Serruys PW,
Leon MB
November 20, 2012 | 10.4244/EIJV8I7A121
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial
Nikolsky E,
Stone GW,
Lee E,
Lansky AJ,
Webb JG,
Cox D,
Brodie B,
Turco M,
Rutherford B,
Kalynych A,
Antoniucci D,
Krucoff M,
Gibbons R,
Fahy M,
Mehran R
September 30, 2009
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
Daemen J,
Simoons M,
Wijns W,
Bagust A,
Bos G,
Bowen J,
Braunwald E,
Camenzind E,
Chevalier B,
Di Mario C,
Fajadet J,
Gitt A,
Guagliumi G,
Hillege H,
James S,
Jüni P,
Kastrati A,
Kloth S,
Kristensen SD,
Krucoff M,
Legrand V,
Pfisterer M,
Rothman M,
Serruys PW,
Silber S,
Steg G,
Tariah I,
Wallentin L,
Windecker S
January 20, 2009
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023